VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Men or women aged 18-60 years                      │ Men or women aged 18-60 years                      │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Primary psychiatric diagnosis of Major Depressive  │ Primary psychiatric diagnosis of Major Depressive  │     100 │
│ Disorder, without psychotic features, confirmed    │ Disorder, without psychotic features, confirmed    │         │
│ via SCID-IV structured diagnostic interview        │ via SCID-IV structured diagnostic interview        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ If the patient is a woman of child-bearing         │ If the patient is a woman of child-bearing         │     100 │
│ potential, she must agree to use an acceptable     │ potential, she must agree to use an acceptable     │         │
│ form of birth control for duration of study        │ form of birth control for duration of study        │         │
│ participation                                      │ participation                                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Able to understand and provide informed consent    │ Able to understand and provide informed consent    │     100 │
│ for participation                                  │ for participation                                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Lifetime history of Bipolar Disorder, Dementia,    │ Lifetime history of Bipolar Disorder, Dementia,    │     100 │
│ Autism Spectrum Disorder, Schizophrenia, or any    │ Autism Spectrum Disorder, Schizophrenia, or any    │         │
│ other Psychotic Disorder                           │ other Psychotic Disorder                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Psychotic symptoms occurring at any time during    │ Psychotic symptoms occurring at any time during    │     100 │
│ the current major depressive episode               │ the current major depressive episode               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Current (past 12 months) diagnosis of Panic        │ Current (past 12 months) diagnosis of Panic        │     100 │
│ disorder, Obsessive Compulsive Disorder,           │ disorder, Obsessive Compulsive Disorder,           │         │
│ Posttraumatic Stress Disorder, Anorexia Nervosa,   │ Posttraumatic Stress Disorder, Anorexia Nervosa,   │         │
│ or Bulimia Nervosa                                 │ or Bulimia Nervosa                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Alcohol or Drug Dependence within 12 months or     │ Alcohol or Drug Dependence within 12 months or     │     100 │
│ Abuse within 3 months (excluding nicotine and      │ Abuse within 3 months (excluding nicotine and      │         │
│ caffeine) of baseline visit, as assessed by        │ caffeine) of baseline visit, as assessed by        │         │
│ history and urine drug screen                      │ history and urine drug screen                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Clinical evidence of a severe Personality          │ Clinical evidence of a severe Personality          │     100 │
│ Disorder, as assessed by the study psychiatrist,   │ Disorder, as assessed by the study psychiatrist,   │         │
│ which would impede participation or completion of  │ which would impede participation or completion of  │         │
│ the trial                                          │ the trial                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Known neurological disorders or documented serious │ Known neurological disorders or documented serious │     100 │
│ head injury                                        │ head injury                                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Serious and unstable medical illnesses including   │ Serious and unstable medical illnesses including   │     100 │
│ cardiovascular disease and cancer                  │ cardiovascular disease and cancer                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Active medical conditions with known mood changes  │ Active medical conditions with known mood changes  │     100 │
│ (endocrine, autoimmune disorders)                  │ (endocrine, autoimmune disorders)                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Current diabetes mellitus                          │ Current diabetes mellitus                          │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ For women, pregnancy, lactation, or unwillingness  │ For women, pregnancy, lactation, or unwillingness  │     100 │
│ to comply with birth control requirements          │ to comply with birth control requirements          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Use of any of the following treatments or any      │ Use of any of the following treatments or any      │     100 │
│ other alternative therapy within 2 weeks of the    │ other alternative therapy within 2 weeks of the    │         │
│ pre-treatment PET scan that may have beneficial    │ pre-treatment PET scan that may have beneficial    │         │
│ effects on mood, including St John's Wort,         │ effects on mood, including St John's Wort,         │         │
│ S-adenosyl methionine (SAMe), n-3 fatty acids, or  │ S-adenosyl methionine (SAMe), n-3 fatty acids, or  │         │
│ light therapy                                      │ light therapy                                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Use of antidepressant medication within 1 month of │ Use of antidepressant medication within 1 month of │     100 │
│ the pre-treatment PET scan (within 5 weeks for     │ the pre-treatment PET scan (within 5 weeks for     │         │
│ fluoxetine and protryptyline)                      │ fluoxetine and protryptyline)                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Clinically significant active suicidal ideation or │ Clinically significant active suicidal ideation or │     100 │
│ self-injurious behavior necessitating immediate    │ self-injurious behavior necessitating immediate    │         │
│ treatment, as determined by the investigator       │ treatment, as determined by the investigator       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Received electroconvulsive therapy in the past 6   │ Received electroconvulsive therapy in the past 6   │     100 │
│ months or during the current depressive episode    │ months or during the current depressive episode    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Currently responding to medication treatment,      │ Currently responding to medication treatment,      │     100 │
│ without clinical reasons to change                 │ without clinical reasons to change                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Current treatment with weekly individual or group  │ Current treatment with weekly individual or group  │     100 │
│ psychotherapy of any type targeted at depressive   │ psychotherapy of any type targeted at depressive   │         │
│ symptoms                                           │ symptoms                                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Contraindications for MRI, including, but not      │ Contraindications for MRI, including, but not      │     100 │
│ limited to pacemaker, aneurysm clips,              │ limited to pacemaker, aneurysm clips,              │         │
│ neurostimulators, cochlear implants, metal in      │ neurostimulators, cochlear implants, metal in      │         │
│ eyes, steel worker, intra-uterine devices for      │ eyes, steel worker, intra-uterine devices for      │         │
│ birth control                                      │ birth control                                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Maintenance or prophylactic therapy for stable     │ Maintenance or prophylactic therapy for stable     │     100 │
│ medical conditions                                 │ medical conditions                                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Hypnotic medication prescribed or approved by the  │ Hypnotic medication prescribed or approved by the  │     100 │
│ study physician, (up to a three doses per week)    │ study physician, (up to a three doses per week)    │         │
│ for insomnia, as long if not the night before a    │ for insomnia, as long if not the night before a    │         │
│ PET/MRI or clinic ratings visit. Antipsychotic     │ PET/MRI or clinic ratings visit. Antipsychotic     │         │
│ medications, whether prescribed for sleep or other │ medications, whether prescribed for sleep or other │         │
│ indications, are prohibited                        │ indications, are prohibited                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Failure to achieve a much improved status (i.e.    │ Failure to achieve a much improved status (i.e.    │      91 │
│ equivalent to \>50% symptom reduction) with 1) any │ equivalent to >50% symptom reduction) with any     │         │
│ lifetime treatment course of CBT (defined as a     │ lifetime treatment course of CBT (defined as a     │         │
│ minimum of 4 sessions of a specified manual-driven │ minimum of 4 sessions of a specified manual-driven │         │
│ therapy by a CBT-trained therapist) or 2) both     │ therapy by a CBT-trained therapist) or             │         │
│ escitalopram and sertraline (defined as a minimum  │ escitalopram (defined as a minimum of 6 weeks of   │         │
│ of 6 weeks of at the minimum effective dose)       │ at least 10 mg/day)                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Screening Hamilton Depression Rating Scale (HAMD)  │ Screening Hamilton Depression Rating Scale (HAMD)  │      97 │
│ ≥ 18; and Baseline HAMD ≥ 15                       │ = 18; and Baseline HAMD = 15                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ QTc \>500 milliseconds on EKG at screening         │ QTc >500 milliseconds on EKG at screening          │      99 │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════════════════════╤═══════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                 │ CHIA Criteria                                 │   Score │
╞═══════════════════════════════════════════════════╪═══════════════════════════════════════════════╪═════════╡
│ Use of concomitant medications with the exception │ Currently responding to medication treatment, │      47 │
│ of                                                │ without clinical reasons to change            │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────┼─────────┤
│ Must have maximum age of 60 Years                 │ Men or women aged 18-60 years                 │      52 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 18 Years                 │ Men or women aged 18-60 years                 │      55 │
╘═══════════════════════════════════════════════════╧═══════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 97
Average Levenshtein Ratio of individual lines: 94.51724137931035
OverAll Ratio: 95.75862068965517
